Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bayerdörffer E[au]:

Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease. Bayerdörffer E et al. BMC Gastroenterol. (2016)

Solitary colonic ulcers. Bayerdörffer E et al. Gastrointest Endosc. (1986)

Helicobacter and gastric MALT lymphoma. Stolte M et al. Gut. (2002)

Search results

Items: 1 to 50 of 147

1.

Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease.

Bayerdörffer E, Bigard MA, Weiss W, Mearin F, Rodrigo L, Dominguez Muñoz JE, Grundling H, Persson T, Svedberg LE, Keeling N, Eklund S.

BMC Gastroenterol. 2016 Apr 14;16:48. doi: 10.1186/s12876-016-0448-x.

2.

Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.

Miehlke S, Hansky K, Schneider-Brachert W, Kirsch C, Morgner A, Madisch A, Kuhlisch E, Bästlein E, Jacobs E, Bayerdörffer E, Lehn N, Stolte M.

Aliment Pharmacol Ther. 2006 Jul 15;24(2):395-403.

3.

Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.

Madisch A, Miehlke S, Neuber F, Morgner A, Kuhlisch E, Rappel S, Lehn N, Bayerdörffer E, Seitz G, Stolte M.

Aliment Pharmacol Ther. 2006 Feb 15;23(4):473-9.

4.

7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.

Antos D, Schneider-Brachert W, Bästlein E, Hänel C, Haferland C, Buchner M, Meier E, Trump F, Stolte M, Lehn N, Bayerdörffer E.

Helicobacter. 2006 Feb;11(1):39-45.

PMID:
16423088
5.

Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.

Wündisch T, Thiede C, Morgner A, Dempfle A, Günther A, Liu H, Ye H, Du MQ, Kim TD, Bayerdörffer E, Stolte M, Neubauer A.

J Clin Oncol. 2005 Nov 1;23(31):8018-24. Epub 2005 Oct 3.

PMID:
16204012
6.

Increased prevalence of colorectal adenomas in women with breast cancer.

Ochsenkühn T, Bayerdörffer E, Meining A, Späth L, Mannes GA, Wiebecke B, Eiermann W, Sackmann M, Göke B.

Digestion. 2005;72(2-3):150-5. Epub 2005 Sep 16.

PMID:
16172552
7.

Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation.

Madisch A, Miehlke S, Bayerdorffer E, Wiedemann B, Antos D, Sievert A, Vieth M, Stolte M, Schulz H.

World J Gastroenterol. 2005 Feb 28;11(8):1182-6.

8.

Oral budesonide therapy improves quality of life in patients with collagenous colitis.

Madisch A, Heymer P, Voss C, Wigginghaus B, Bästlein E, Bayerdörffer E, Meier E, Schimming W, Bethke B, Stolte M, Miehlke S.

Int J Colorectal Dis. 2005 Jul;20(4):312-6. Epub 2004 Nov 11.

PMID:
15549326
9.

Helicobacter pylori in gastric corpus of patients 20 years after partial gastric resection.

Kirsch C, Madisch A, Piehler P, Bayerdorffer E, Stolte M, Miehlke S.

World J Gastroenterol. 2004 Sep 1;10(17):2557-9.

10.

[Helicobacter treatment. Proven and new antibiotic combinations for the treatment of recurrences].

Bayerdörffer E, Lehn N, Stolte M.

Dtsch Med Wochenschr. 2004 Feb 27;129(9):443-6. Review. German. No abstract available.

PMID:
14970917
11.

Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany.

Madisch A, Kulich KR, Malfertheiner P, Ziegler K, Bayerdörffer E, Miehlke S, Labenz J, Carlsson J, Wiklund IK.

Z Gastroenterol. 2003 Dec;41(12):1137-43.

PMID:
14661122
12.

Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease.

Kulich KR, Malfertheiner P, Madisch A, Labenz J, Bayerdörffer E, Miehlke S, Carlsson J, Wiklund IK.

Health Qual Life Outcomes. 2003 Oct 28;1:62.

13.

Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance.

Miehlke S, Schneider-Brachert W, Bästlein E, Ebert S, Kirsch C, Haferland C, Buchner M, Neumeyer M, Vieth M, Stolte M, Lehn N, Bayerdörffer E.

Aliment Pharmacol Ther. 2003 Oct 15;18(8):799-804.

14.

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.

Miehlke S, Kirsch C, Schneider-Brachert W, Haferland C, Neumeyer M, Bästlein E, Papke J, Jacobs E, Vieth M, Stolte M, Lehn N, Bayerdörffer E.

Helicobacter. 2003 Aug;8(4):310-9.

PMID:
12950604
15.

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

Lauritsen K, Devière J, Bigard MA, Bayerdörffer E, Mózsik G, Murray F, Kristjánsdóttir S, Savarino V, Vetvik K, De Freitas D, Orive V, Rodrigo L, Fried M, Morris J, Schneider H, Eklund S, Larkö A.

Aliment Pharmacol Ther. 2003 Feb;17 Suppl 1:24; discussion 25-7.

16.

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

Lauritsen K, Devière J, Bigard MA, Bayerdörffer E, Mózsik G, Murray F, Kristjánsdóttir S, Savarino V, Vetvik K, De Freitas D, Orive V, Rodrigo L, Fried M, Morris J, Schneider H, Eklund S, Larkö A; Metropole study results.

Aliment Pharmacol Ther. 2003 Feb;17(3):333-41.

17.

Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial.

Miehlke S, Heymer P, Bethke B, Bästlein E, Meier E, Bartram HP, Wilhelms G, Lehn N, Dorta G, DeLarive J, Tromm A, Bayerdörffer E, Stolte M.

Gastroenterology. 2002 Oct;123(4):978-84.

PMID:
12360457
18.

Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme.

Malfertheiner P, Dent J, Zeijlon L, Sipponen P, Veldhuyzen Van Zanten SJ, Burman CF, Lind T, Wrangstadh M, BayerdOrffer E, Lonovics J.

Aliment Pharmacol Ther. 2002 Aug;16(8):1431-42.

19.

Expression of G1 phase cyclins in human gastric cancer and gastric mucosa of first-degree relatives.

Miehlke S, Yu J, Ebert M, Szokodi D, Vieth M, Kuhlisch E, Buchcik R, Schimmin W, Wehrmann U, Malfertheiner P, Ehninger G, Bayerdörffer E, Stolte M.

Dig Dis Sci. 2002 Jun;47(6):1248-56.

PMID:
12064799
20.

Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.

Knippig C, Arand F, Leodolter A, Nilius M, Bayerdörffer E, Klein U, Malfertheiner P.

Z Gastroenterol. 2002 Jun;40(6):383-7.

PMID:
12055660
21.

Helicobacter and gastric MALT lymphoma.

Stolte M, Bayerdörffer E, Morgner A, Alpen B, Wündisch T, Thiede C, Neubauer A.

Gut. 2002 May;50 Suppl 3:III19-24. Review.

22.

The presence of immunoglobulins in the gastric juice of patients infected with Helicobacter pylori is related to a reduced secretion of acid.

Meining A, Wick M, Miehlke S, Bayerdörffer E, Stolte M, Sackmann M, Ochsenkühn T.

Helicobacter. 2002 Feb;7(1):67-70.

PMID:
11886476
23.

Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis?

Meining A, Morgner A, Miehlke S, Bayerdörffer E, Stolte M.

Best Pract Res Clin Gastroenterol. 2001 Dec;15(6):983-98. Review.

PMID:
11866488
24.

Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.

Morgner A, Miehlke S, Stolte M, Neubauer A, Alpen B, Thiede C, Klann H, Hierlmeier FX, Ell C, Ehninger G, Bayerdörffer E.

World J Gastroenterol. 2001 Apr;7(2):248-53.

25.

Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).

Miehlke S, Kirsch C, Dragosics B, Gschwantler M, Oberhuber G, Antos D, Dite P, Läuter J, Labenz J, Leodolter A, Malfertheiner P, Neubauer A, Ehninger G, Stolte M, Bayerdörffer E.

World J Gastroenterol. 2001 Apr;7(2):243-7.

26.

Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy.

Alpen B, Thiede C, Wündisch T, Bayerdörffer E, Stolte M, Neubauer A.

Clin Lymphoma. 2001 Sep;2(2):103-8. Review.

PMID:
11707850
27.

Long-term follow-up of gastric MALT lymphoma after H. pylori eradication.

Morgner A, Thiede C, Bayerdörffer E, Alpen B, Wündisch T, Neubauer A, Stolte M.

Curr Gastroenterol Rep. 2001 Dec;3(6):516-22. Review.

PMID:
11696290
28.

Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication.

Müller H, Rappel S, Wündisch T, Bayerdörffer E, Stolte M.

Digestion. 2001;64(1):30-9.

PMID:
11549834
29.

Treatment of Helicobacter pylori infection.

Miehlke S, Bayerdörffer E, Graham DY.

Semin Gastrointest Dis. 2001 Jul;12(3):167-79. Review.

PMID:
11478749
30.

Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease.

Miehlke S, Yu J, Schuppler M, Frings C, Kirsch C, Negraszus N, Morgner A, Stolte M, Ehninger G, Bayerdörffer E.

Am J Gastroenterol. 2001 Apr;96(4):1008-13.

PMID:
11316139
31.

Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.

Morgner A, Miehlke S, Fischbach W, Schmitt W, Müller-Hermelink H, Greiner A, Thiede C, Schetelig J, Neubauer A, Stolte M, Ehninger G, Bayerdörffer E.

J Clin Oncol. 2001 Apr 1;19(7):2041-8.

PMID:
11283137
32.

Inducible nitric oxide synthase expression before and after eradication of Helicobacter pylori in different forms of gastritis.

Antos D, Enders G, Rieder G, Stolte M, Bayerdörffer E, Hatz RA.

FEMS Immunol Med Microbiol. 2001 Mar;30(2):127-31.

33.

Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma.

Thiede C, Wündisch T, Alpen B, Neubauer B, Morgner A, Schmitz M, Ehninger G, Stolte M, Bayerdörffer E, Neubauer A; German MALT Lymphoma Study Group.

J Clin Oncol. 2001 Mar 15;19(6):1600-9.

PMID:
11250988
34.

[Precancerous risk markers in Helicobacter pylori gastritis].

Miehlke S, Bayerdörffer E, Ehninger G, Stolte M.

Pathologe. 2001 Jan;22(1):31-6. Review. German.

PMID:
11225442
35.

[Extent, topography and symptoms of Helicobacter pylori gastrtitis. Phenotyping for accurate diagnosis and therapy?].

Meining A, Bayerdörffer E, Stolte M.

Pathologe. 2001 Jan;22(1):13-8. Review. German.

PMID:
11225439
36.

The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.

Bardhan K, Bayerdörffer E, Veldhuyzen Van Zanten SJ, Lind T, Mégraud F, Delchier JC, Hellblom M, Stubberöd A, Burman CF, Gromark P, Zeijlon L.

Helicobacter. 2000 Dec;5(4):196-201.

PMID:
11179983
37.

Helicobacter pylori associated gastric B cell MALT lymphoma: predictive factors for regression.

Morgner A, Bayerdörffer E, Neubauer A, Stolte M.

Gut. 2001 Mar;48(3):290-2. No abstract available.

38.

Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.

Morgner A, Bayerdörffer E, Neubauer A, Stolte M.

Gastroenterol Clin North Am. 2000 Sep;29(3):593-607. Review.

PMID:
11030075
39.

Gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: management of the disease.

Bayerdörffer E, Morgner A.

Dig Liver Dis. 2000 Apr;32(3):192-4. Review. No abstract available.

PMID:
10975767
40.

The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany.

Miehlke S, Kirsch C, Agha-Amiri K, Günther T, Lehn N, Malfertheiner P, Stolte M, Ehninger G, Bayerdörffer E.

Int J Cancer. 2000 Aug 1;87(3):322-7.

41.

Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole.

Schulz H, Miehlke S, Antos D, Schentke KU, Vieth M, Stolte M, Bayerdörffer E.

Gastrointest Endosc. 2000 Jun;51(6):659-63.

PMID:
10840296
42.

Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer.

Ebert MP, Yu J, Miehlke S, Fei G, Lendeckel U, Ridwelski K, Stolte M, Bayerdörffer E, Malfertheiner P.

Br J Cancer. 2000 Jun;82(11):1795-800.

43.

Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial.

Thiede C, Wündisch T, Neubauer B, Alpen B, Morgner A, Ritter M, Ehninger G, Stolte M, Bayerdörffer E, Neubauer A.

Recent Results Cancer Res. 2000;156:125-33.

PMID:
10802872
44.

Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection.

Morgner A, Lehn N, Andersen LP, Thiede C, Bennedsen M, Trebesius K, Neubauer B, Neubauer A, Stolte M, Bayerdörffer E.

Gastroenterology. 2000 May;118(5):821-8.

PMID:
10784580
45.

alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives.

Yu J, Ebert MP, Miehlke S, Rost H, Lendeckel U, Leodolter A, Stolte M, Bayerdörffer E, Malfertheiner P.

Gut. 2000 May;46(5):639-44.

46.

Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives.

Yu J, Miehlke S, Ebert MP, Hoffmann J, Breidert M, Alpen B, Starzynska T, Stolte Prof M, Malfertheiner P, Bayerdörffer E.

Cancer. 2000 Apr 15;88(8):1801-6.

PMID:
10760755
47.

Gastric MALT lymphoma and its relationship to Helicobacter pylori infection: management and pathogenesis of the disease.

Morgner A, Bayerdörffer E, Neubauer A, Stolte M.

Microsc Res Tech. 2000 Mar 15;48(6):349-56. Review.

PMID:
10738316
48.
49.

Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection.

Bayerdörffer E, Lonovics J, Dité P, Díete U, Domján L, Kisfalvi I, Mégraud F, Pap A, Sipponen P, Burman CF, Zeijlon L.

Aliment Pharmacol Ther. 1999 Dec;13(12):1639-45.

50.

Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritis.

Breidert M, Miehlke S, Glasow A, Orban Z, Stolte M, Ehninger G, Bayerdörffer E, Nettesheim O, Halm U, Haidan A, Bornstein SR.

Scand J Gastroenterol. 1999 Oct;34(10):954-61.

PMID:
10563663

Supplemental Content

Loading ...
Support Center